Overview
Brachytelephalangy-dysmorphism-Kallmann syndrome is an extremely rare genetic condition that combines several features affecting different parts of the body. The name describes its main characteristics: brachytelephalangy refers to unusually short end bones (distal phalanges) of the fingers and toes, dysmorphism means distinctive facial features, and Kallmann syndrome refers to a combination of reduced or absent sense of smell (anosmia or hyposmia) along with delayed or absent puberty due to a hormone deficiency called hypogonadotropic hypogonadism. This means the brain does not properly signal the body to produce the sex hormones needed for puberty. Patients may have a range of facial features including a broad nasal bridge, widely spaced eyes, and other subtle differences in facial structure. The short fingertips and toes are often noticeable from birth or early childhood. Because puberty may not begin on its own, affected individuals often need hormone replacement therapy to develop secondary sexual characteristics and to support bone health and fertility. The condition may also be associated with other findings such as intellectual differences or additional skeletal abnormalities, though the severity varies between individuals. Treatment is mainly supportive and symptom-based. Hormone therapy is the cornerstone for managing the Kallmann syndrome component, while other features may require monitoring by multiple specialists. Because this condition is so rare, management is often individualized based on each patient's specific needs.
Key symptoms:
Short fingertips and toesReduced or absent sense of smellDelayed or absent pubertyDistinctive facial featuresWidely spaced eyesBroad nasal bridgeSmall or underdeveloped genitalia in malesLow levels of sex hormonesPossible mild intellectual disabilityShort stature or growth delaysSkeletal abnormalities of the hands and feetPossible infertility
Clinical phenotype terms (19)— hover any for plain English
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Brachytelephalangy-dysmorphism-Kallmann syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Brachytelephalangy-dysmorphism-Kallmann syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Brachytelephalangy-dysmorphism-Kallmann syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Brachytelephalangy-dysmorphism-Kallmann syndrome.
Community
No community posts yet. Be the first to share your experience with Brachytelephalangy-dysmorphism-Kallmann syndrome.
Start the conversation →Latest news about Brachytelephalangy-dysmorphism-Kallmann syndrome
No recent news articles for Brachytelephalangy-dysmorphism-Kallmann syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic testing should be done to confirm the diagnosis?,When should hormone replacement therapy be started, and what are the options?,How will we monitor bone health over time?,What are the chances of achieving fertility with treatment?,Are there any other organs or systems that should be screened?,Is there a risk of passing this condition to future children?,What support services are available for emotional and developmental needs?
Common questions about Brachytelephalangy-dysmorphism-Kallmann syndrome
What is Brachytelephalangy-dysmorphism-Kallmann syndrome?
Brachytelephalangy-dysmorphism-Kallmann syndrome is an extremely rare genetic condition that combines several features affecting different parts of the body. The name describes its main characteristics: brachytelephalangy refers to unusually short end bones (distal phalanges) of the fingers and toes, dysmorphism means distinctive facial features, and Kallmann syndrome refers to a combination of reduced or absent sense of smell (anosmia or hyposmia) along with delayed or absent puberty due to a hormone deficiency called hypogonadotropic hypogonadism. This means the brain does not properly signa
At what age does Brachytelephalangy-dysmorphism-Kallmann syndrome typically begin?
Typical onset of Brachytelephalangy-dysmorphism-Kallmann syndrome is neonatal. Age of onset can vary across affected individuals.